SMARCA4 and non-small cell lung carcinoma: A separate study involving a cohort of 1013 NSCLC cases used for microarray analysis found that BAF subunit (ARID1A, SMARCA4, SMARCA2, and/or ARID1B) expression correlated with PD‐L1‐positive status and high TMB [31].